A randomized‐controlled trial to evaluate the app‐based multimodal weight loss program <i>zanadio</i> for patients with obesity

Abstract

This study showed that adults with obesity who have used zanadio achieved a significant and clinically relevant weight loss within 12 months and improved further obesity-related health variables compared with a control group. Because of its effectiveness and flexible applicability, the app-based multimodal treatment zanadio might alleviate the present care gap for patients with obesity in Germany.